![](https://www.diabetesnews.com/wp-content/uploads/2013/01/cancer-1024_170075k-150x150.jpg)
In previous studies, metformin has been shown to decrease the risk of cancer in type 2 diabetes. A recent meta-analysis showed a 34% reduction in the incidence of any cancer and a 33% reduction in cancer mortality; however, the studies are prone to bias and failed to confirm the results of observational studies.